Senior Scientist, Small Molecule Method Development and Validation

Lancaster, PA, US

In-personFull time roleSenior Level

4 months ago

About the Job

Job Summary: Eurofins Small Molecule Method Establishment is seeking a Senior Scientist to perform method validations, method transfers, and method verification activities on APIs and finished products. The team is seeking candidates with expertise in method development and/or method validation.

Applies GMP in all areas of responsibility, as appropriate.
Performing a large variety of analytical tasks for the validation of analytical methods used in the testing of drug products and raw materials by means of various procedures including HPLC, GC, UV/Vis, and dissolution.
Reading, understanding, and interpreting diverse analytical procedures.
Conducting analytical investigations.
Troubleshoot instrumentation and communicate with vendors when required.
Train and mentor junior staff in laboratory procedures.
Manage and discuss projects with clients.

About the Company

Eurofins

Luxembourg, Luxembourg

5000 +

Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and the environment safer, healthier and more sustainable. From the food you eat to the medicines you rely on, Eurofins works with the biggest companies in the world to ensure the products they supply are safe, their ingredients are authentic and labelling is accurate. Eurofins is a global leader in food, environmental, pharmaceutical and cosmetic product testing and in agroscience CRO services. It is also one of the global independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, CDMO, advanced material sciences and in the support of clinical studies. Since 1987, Eurofins has grown from one laboratory in Nantes, France to ca. 62,000 staff across a network of independent companies in 62 countries, operating over 900 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.